33107640|t|Telomeric alterations in the default mode network during the progression of Alzheimer's disease: Selective vulnerability of the precuneus.
33107640|a|AIMS: Although telomere length (TL) and telomere maintenance proteins (shelterins) are markers of cellular senescence and peripheral blood biomarkers of Alzheimer's disease (AD), little information is available on telomeric alterations during the prodromal stage (MCI) of AD. We investigated TL in the default mode network (DMN), which underlies episodic memory deficits in AD, as well as shelterin protein and mRNA levels in the precuneus (PreC). METHODS: Telomere length was evaluated in DMN hubs and visual cortex using quantitative PCR (qPCR). In the PreC, western blotting and NanoString nCounter expression analyses evaluated shelterin protein and mRNA levels, respectively, in cases with an antemortem clinical diagnosis of no cognitive impairment (NCI), MCI and AD. RESULTS: TL was significantly reduced in the PreC in MCI and AD compared to NCI, but stable in frontal, inferior temporal, posterior cingulate and visual cortex. PreC TL correlated significantly with performance on cognitive tests. NCI cases with high vs low Braak scores displayed significantly shorter TL in posterior cingulate and frontal cortex, which correlated significantly with neuritic and diffuse amyloid-beta plaque counts. Shelterin protein levels (TIN2, TRF1, TRF2 and POT1) declined in MCI and AD compared to NCI. The PreC displayed stable expression of shelterins TERF1, TERF2, POT1, RAP1 and TPP1, while TINF2 mRNA significantly increased in AD compared to NCI. CONCLUSIONS: These findings indicate a selective vulnerability to telomere attrition within different nodes of the DMN in prodromal AD and in aged NCI individuals with high Braak scores highlighting a putative role in the pathogenesis of AD.
33107640	76	95	Alzheimer's disease	Disease	MESH:D000544
33107640	292	311	Alzheimer's disease	Disease	MESH:D000544
33107640	313	315	AD	Disease	MESH:D000544
33107640	403	406	MCI	Disease	
33107640	411	413	AD	Disease	MESH:D000544
33107640	485	509	episodic memory deficits	Disease	MESH:D008569
33107640	513	515	AD	Disease	MESH:D000544
33107640	873	893	cognitive impairment	Disease	MESH:D003072
33107640	895	898	NCI	Disease	MESH:D003072
33107640	901	904	MCI	Disease	
33107640	909	911	AD	Disease	MESH:D000544
33107640	966	969	MCI	Disease	
33107640	974	976	AD	Disease	MESH:D000544
33107640	989	992	NCI	Disease	MESH:D003072
33107640	1145	1148	NCI	Disease	MESH:D003072
33107640	1320	1332	amyloid-beta	Gene	351
33107640	1374	1378	TIN2	Gene	26277
33107640	1380	1384	TRF1	Gene	7013
33107640	1386	1390	TRF2	Gene	7014
33107640	1395	1399	POT1	Gene	25913
33107640	1413	1416	MCI	Disease	
33107640	1421	1423	AD	Disease	MESH:D000544
33107640	1436	1439	NCI	Disease	MESH:D003072
33107640	1492	1497	TERF1	Gene	7013
33107640	1499	1504	TERF2	Gene	7014
33107640	1506	1510	POT1	Gene	25913
33107640	1512	1516	RAP1	Gene	54386
33107640	1521	1525	TPP1	Gene	1200
33107640	1533	1538	TINF2	Gene	26277
33107640	1571	1573	AD	Disease	MESH:D000544
33107640	1586	1589	NCI	Disease	MESH:D003072
33107640	1723	1725	AD	Disease	MESH:D000544
33107640	1738	1741	NCI	Disease	MESH:D003072
33107640	1829	1831	AD	Disease	MESH:D000544
33107640	Negative_Correlation	MESH:D000544	25913
33107640	Association	MESH:D003072	7014
33107640	Association	MESH:D000544	26277
33107640	Association	MESH:D003072	7013
33107640	Negative_Correlation	MESH:D000544	7014
33107640	Association	MESH:D003072	26277
33107640	Negative_Correlation	MESH:D000544	7013
33107640	Association	MESH:D003072	25913

